台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    85.9
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    69
  • 產業
    上市 生技醫療類股▼0.22%
  • 332人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
佳醫 (4104)籌碼相關-富邦-頭份 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-頭份 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/13284.5500.0084.902772.57%
2025/01/02185.8000.0085.801741.35%
2024/12/24186.2000.0086.001751.32%
2024/12/20185.9000.0085.901751.33%
2024/12/1600.000.786.8086.50-0.774-0.99%
2024/12/06186.8000.0086.901721.38%
2024/12/04187.0000.0087.101721.37%
2024/11/21186.8000.0086.801791.25%
2024/11/15185.9000.0086.101851.17%
2024/11/12187.0000.0087.001891.11%
2024/11/11087.6000.0087.500890.03%
2024/10/09087.6000.0087.4001160.03%
2024/10/07187.6000.0087.6011180.84%
2024/09/2300.00188.0087.60-1123-0.81%
2024/09/10087.4000.0086.9001310.02%
2024/08/15192.0000.0092.3011400.72%
2024/08/12089.704.189.5089.50-4137-2.93%
2024/08/0900.00187.8087.50-1136-0.73%
2024/08/06186.4000.0086.9011400.71%
2024/07/3100.000.188.8088.90-0.1131-0.04%
2024/07/29188.4000.0088.8011370.73%
2024/07/1800.001.189.2389.40-1.1136-0.81%
2024/07/12589.3000.0089.3051643.03%
2024/07/11089.6000.0089.3001700.01%
2024/07/1000.00089.6089.500178-0.01%
2024/07/09189.5000.0089.4011840.54%
2024/06/2500.00190.5090.00-1211-0.47%
2024/06/2400.00490.4390.20-4217-1.84%
2024/06/19190.3000.0090.2012220.45%
2024/06/12090.0000.0090.0002380.01%
2024/05/10091.9000.0091.8002960.01%
2024/05/061092.2200.0092.40102933.41%
2024/04/19589.5200.0090.0052801.78%
2024/04/1700.00594.5094.60-5259-1.93%
2024/04/16294.0000.0094.0022540.79%
2024/04/10095.90196.2095.40-1230-0.42%
2024/03/22194.4000.0094.2012040.49%
2024/03/2000.00294.2094.10-2201-0.99%
2024/03/19193.7000.0093.5011970.51%
2024/03/1300.00192.7092.30-1195-0.51%
2024/03/12292.90192.9092.9011910.52%
2024/03/08089.6000.0089.2001700.01%
2024/03/07189.3000.0089.6011670.60%
2024/03/04190.6000.0090.3011590.63%
2024/03/010.491.0000.0091.200.41530.26%
2024/02/20188.3000.0088.3011360.73%
2024/02/05087.3000.0087.0001350.02%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音